drugset / Trial / NCT05071352

Adjuvant Continuous Infusion of Nefopam Versus Standard of Care in Mechanically Ventilated Critically Ill Patients: Randomized Double-blind Controlled Study

NCT05071352

Phase 3 Completed 60 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this prospective, randomized, active control, double blinded study is to assess the effect and safety of continuous infusion nefopam in mechanically ventilated ICU patients compared to standard of care. It is being hypothesized that continuous infusion nefopam will reduce opioid use with acceptable safety profile compared to standard of care.

Timeline

Start
2021-10-01
Primary completion
2023-03-01
Completion
2023-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Nefopam Small molecule 5 mg Intravenous

Indications

No indication recorded.